| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |